Clinical Trial Update: A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176 [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 open-label study evaluating the absorption, metabolism, excretion, and absolute bioavailability of ALS-008176.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• ALS-008176

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED